Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Risperidone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112794849A reveals a green synthesis for risperidone intermediates, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel cyclization method for Risperidone improves purity and reduces costs. Ideal for pharmaceutical intermediate suppliers seeking scalable solutions.
Patent CN112624992B reveals a purification breakthrough for risperidone intermediates. Achieve 99.9% purity and stable supply chain for API manufacturing.
Patent CN1720228A details a novel acetate salt method for enriching Z-oxime intermediates, enhancing yield and purity for reliable pharmaceutical intermediates supply chains.
Patent CN112794849B details a novel, eco-friendly route to 3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, eliminating toxic POCl3 and enhancing supply chain stability.
Novel green synthesis of risperidone intermediate avoiding POCl3. High yield, scalable process for reliable pharmaceutical intermediate supply.